Modulating the Blood-Brain Barrier: A Comprehensive Review

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2021 Nov 27

PMID 34834395

Citations 16

Authors

Rory Whelan

Grainne C Hargaden

Andrew J S Knox

Affiliations

Soon will be listed here.

Abstract

The highly secure blood-brain barrier (BBB) restricts drug access to the brain, limiting the molecular toolkit for treating central nervous system (CNS) diseases to small, lipophilic drugs. Development of a safe and effective BBB modulator would revolutionise the treatment of CNS diseases and future drug development in the area. Naturally, the field has garnered a great deal of attention, leading to a vast and diverse range of BBB modulators. In this review, we summarise and compare the various classes of BBB modulators developed over the last five decades-their recent advancements, advantages and disadvantages, while providing some insight into their future as BBB modulators.

Citing Articles

Non-Drug and Non-Invasive Therapeutic Options in Alzheimer's Disease.

Sovrea A, Bosca A, Dronca E, Constantin A, Crintea A, Sufletel R Biomedicines. 2025; 13(1).

PMID: 39857667 PMC: 11760896. DOI: 10.3390/biomedicines13010084.

The canine blood-brain barrier in health and disease: focus on brain protection.

Bassalo D, Matthews S, Bloise E Vet Q. 2025; 45(1):12-32.

PMID: 39791202 PMC: 11727060. DOI: 10.1080/01652176.2025.2450041.

Could encapsulation of natural compounds in BBB-permeable nanocarriers produce effective Alzheimer's disease treatments?.

Ramalho M, Andrade S, Loureiro J, Pereira M Nanomedicine (Lond). 2024; 20(5):435-438.

PMID: 39727082 PMC: 11875461. DOI: 10.1080/17435889.2024.2444859.

Delivery of Neuroregenerative Proteins to the Brain for Treatments of Neurodegenerative Brain Diseases.

Ebert E, Schwinghamer K, Siahaan T Life (Basel). 2024; 14(11).

PMID: 39598254 PMC: 11595909. DOI: 10.3390/life14111456.

Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC - What is Coming Next?.

Bohley M, Leroux J Adv Sci (Weinh). 2024; 11(33):e2400843.

PMID: 38884149 PMC: 11434117. DOI: 10.1002/advs.202400843.

References

Kovacs Z, Tu T, Sundby M, Qureshi F, Lewis B, Jikaria N . MRI and histological evaluation of pulsed focused ultrasound and microbubbles treatment effects in the brain. Theranostics. 2018; 8(17):4837-4855. PMC: 6160777. DOI: 10.7150/thno.24512. View

Rinaldi C, Wood M . Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat Rev Neurol. 2017; 14(1):9-21. DOI: 10.1038/nrneurol.2017.148. View

Carpentier A, Canney M, Vignot A, Reina V, Beccaria K, Horodyckid C . Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med. 2016; 8(343):343re2. DOI: 10.1126/scitranslmed.aaf6086. View

da Fonseca C, Simao M, Lins I, Caetano R, Futuro D, Quirico-Santos T . Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma. J Cancer Res Clin Oncol. 2010; 137(2):287-93. DOI: 10.1007/s00432-010-0873-0. View

Mrsny R, Brown G, Gerner-Smidt K, Buret A, Meddings J, Quan C . A key claudin extracellular loop domain is critical for epithelial barrier integrity. Am J Pathol. 2008; 172(4):905-15. PMC: 2276422. DOI: 10.2353/ajpath.2008.070698. View

Lima W, de Brito J, Nascimento Cardoso V, Antunes Fernandes S . In-depth characterization of antibacterial activity of melittin against Staphylococcus aureus and use in a model of non-surgical MRSA-infected skin wounds. Eur J Pharm Sci. 2020; 156:105592. DOI: 10.1016/j.ejps.2020.105592. View

LEHMANN J, HERRICK J . Biologic reactions to cavitation, a consideration for ultrasonic therapy. Arch Phys Med Rehabil. 1953; 34(2):86-98. View

Xiong Y, Hla T . S1P control of endothelial integrity. Curr Top Microbiol Immunol. 2014; 378:85-105. PMC: 4240614. DOI: 10.1007/978-3-319-05879-5_4. View

Galla N, Chiang G, Chakraborty S, Singh R, Tsiouris A, Boockvar J . Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma. Neuroradiology. 2017; 59(5):499-505. DOI: 10.1007/s00234-017-1820-4. View

10.

Song K, Fasano A, Eddington N . Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A. Int J Pharm. 2007; 351(1-2):8-14. DOI: 10.1016/j.ijpharm.2007.09.011. View

11.

Gregor A, Lind M, Newman H, Grant R, Hadley D, Barton T . Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group. J Neurooncol. 2000; 44(2):137-45. DOI: 10.1023/a:1006379332212. View

12.

Hurst R, Clark J . Alterations in transendothelial electrical resistance by vasoactive agonists and cyclic AMP in a blood-brain barrier model system. Neurochem Res. 1998; 23(2):149-54. DOI: 10.1023/a:1022420606634. View

13.

Hsu P, Wei K, Huang C, Wen C, Yen T, Liu C . Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound. PLoS One. 2013; 8(2):e57682. PMC: 3584045. DOI: 10.1371/journal.pone.0057682. View

14.

Xue L, Barrow A, Fleming V, Hunter M, Ogg G, Klenerman P . Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2. J Immunol. 2011; 188(2):694-702. PMC: 3272457. DOI: 10.4049/jimmunol.1102474. View

15.

Kim H, Lee S, Chiu A, Yoo S, Park S . Estimation of the spatial profile of neuromodulation and the temporal latency in motor responses induced by focused ultrasound brain stimulation. Neuroreport. 2014; 25(7):475-9. PMC: 3979873. DOI: 10.1097/WNR.0000000000000118. View

16.

Ji R, Karakatsani M, Burgess M, Smith M, Murillo M, Konofagou E . Cavitation-modulated inflammatory response following focused ultrasound blood-brain barrier opening. J Control Release. 2021; 337:458-471. PMC: 8440441. DOI: 10.1016/j.jconrel.2021.07.042. View

17.

Kim D, Bynoe M . A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier. J Clin Invest. 2016; 126(5):1717-33. PMC: 4855938. DOI: 10.1172/JCI76207. View

18.

Neuwelt E, GLASBERG M, Frenkel E, Barnett P . Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies. Ann Neurol. 1983; 14(3):316-24. DOI: 10.1002/ana.410140310. View

19.

Magara A, Buhler R, Moser D, Kowalski M, Pourtehrani P, Jeanmonod D . First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease. J Ther Ultrasound. 2014; 2:11. PMC: 4266014. DOI: 10.1186/2050-5736-2-11. View

20.

Godinho B, Gilbert J, Haraszti R, Coles A, Biscans A, Roux L . Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization Assay. Nucleic Acid Ther. 2017; 27(6):323-334. PMC: 5706627. DOI: 10.1089/nat.2017.0690. View